Urinary proteomics in obstructive sleep apnoea and obesity

European Journal of Clinical Investigation

Volumn 44, Issue 11, 2014, Pages 1104-1115

  Seetho, Ian W ^a   Siwy, Justyna ^b,c   Albalat, Amaya ^c   Mullen, William ^c   Mischak, Harald ^c   Parker, Robert J ^d   Craig, Sonya ^d   Duffy, Nick ^d   Hardy, Kevin J ^e   Burniston, Jatin G ^f   Wilding, John P H ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e ST HELENS AND KNOWSLEY TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^f LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Obesity; Obstructive sleep apnoea; Urinary proteomics

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; COLLAGEN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POLYPEPTIDE; TRIACYLGLYCEROL; PEPTIDE;

ADULT; ALCOHOL CONSUMPTION; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; CAPILLARY ELECTROPHORESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; NECK CIRCUMFERENCE; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEOMICS; SLEEP DISORDERED BREATHING; SPIROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PROCEDURES; SLEEP APNEA, OBSTRUCTIVE; URINE;

CASE-CONTROL STUDIES; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; OBESITY; PEPTIDES; PROTEOMICS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84925968922     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12346     Document Type: Article

References (55)

1. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-8.
2. Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol 2011;26:541-7.
3. Tasali E, Mokhlesi B, Van Canter E. Obstructive sleep apnea and type 2 diabetes - interacting epidemics. Chest 2008;133:496-506.
4. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41.
5. Peppard PE, Young T, Barnet JH, Palta M, Hagen E, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-14.
6. Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 2008;5:185-92.
7. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea - a matched controlled study. Am J Respir Crit Care Med 2007;175:190-5.
8. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005;142:187-97.
9. Flemons WW, Buysse D, Redline S, Pack A, Strohl K, Wheatley J et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
10. Flemons WW, Littner MR, Rowley JA, Gay P, Anderson WM, Hudgel DW et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003;124:1543-79.
11. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
12. Meston N, Davies RJO, Mullins R, Jenkinson C, Wass JAH, Stradling JR. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003;254:447-54.
13. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bentley CM, Bixler EO et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007;92:4199-207.
14. Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 2009;51:303-12.
15. Drager LF, Jun JC, Polotsky VY. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 2010;24:843-51.
16. Fletcher EC. Obstructive sleep apnea and the kidney. J Am Soc Nephrol 1993;4:1111-21.
17. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010;7:677-85.
18. Chou YT, Lee PH, Yang CT, Lin CL, Veasey S, Chuang LP et al. Obstructive sleep apnoea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant 2011;26:2244-50.
19. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32-5.
20. Tsioufis C, Thomppoulos C, Dimitriadis K, Amfilochiou A, Tsiachris D, Selima M et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 2008;52:285-93.
21. Oflaz H, Cuhadaroglu C, Pamukcu B, Meric M, Ece T, Kasikcioglu E et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006;73:751-6.
22. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009;32:447-70.
23. Ahmed FE. The role of capillary electrophoresis-mass spectrometry to proteome analysis and biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:1963-81.
24. Mischak H, Schanstra JP. CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 2011;5:9-23.
25. Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 2005;26:2797-808.
26. Delles C, Schiffer E, Von Zur Muhlen C, Peter K, Rossing P, Parving H-H et al. Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens 2010;28:2316-22.
27. Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA et al. Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008;19:1283-90.
28. Good DM, Zürbig P, Argiles A, Bauer HW, Behrens G, Coon JJ et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010;9:2424-37.
29. Coon JJ, Zürbig P, Dakna M, Dominicza AF, Decramer S, Fliser D et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2008;2:964-73.
30. Siwy J, Mullen W, Golovko I, Franke J, Zürbig P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 2011;5:367-74.
31. Caylak E. Molecular Genetics of Sleep Disorders. In eLS. Chichester: John Wiley & Sons, Ltd.; 2011. doi: 10.1002/9780470015902.a0022434.
32. Caylak E. The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Genet A 2009;149A:2612-26.
33. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PloS Med 2007;4:e296.
34. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
35. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JPA, Kirsch-Volders M et al. STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med 2011;8:e1001117.
36. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
37. Gozal D, Jortani S, Snow AB, Kheirandish-Gozal L, Bhattacharjee R, Kim J et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009;180:1253-61.
38. Krishna J, Shah ZA, Merchant M, Klein JB, Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006;7:221-7.
39. Snow A, Gozal D, Valdes R, Jortani SA. Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Methods Mol Biol 2010;641:223-41.
40. Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentic AM. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 2000;83:115-22.
41. Nunez C, Kovera AJ, Pietrobelli A, Heshka S, Horlick M, Kehayias JJ et al. Body composition in children and adults by air displacement plethysmography. Eur J Clin Nutr 1999;53:382-7.
42. Fields DA, Goran MI, McCrory MA. Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr 2002;75:453-67.
43. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993;103:30-6.
44. Cleeman JI, Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
45. Albalat A, Franke J, Gonzalez J, Mischak H, Zürbig P. Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease. Methods Mol Biol 2013;919:203-13.
46. Neuhoff NV, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A et al. Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 2004;18:149-56.
47. Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res 2009;8:268-81.
48. Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S et al. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 2006;27:2111-25.
49. Dakna M, Harris K, Kalousis A, Carpentier S, Kolch W, Schanstra JP et al. Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics 2010;11:594.
50. Seetho IW, Wilding JPH. Screening for obstructive sleep apnoea in obesity and diabetes potential for future approaches. Eur J Clin Invest 2013;43:640-55.
51. Wang H, Tian JL, Feng SZ, Sun N, Chen BY, Zhang Y. The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet. Sleep Breath 2013;17:957-65.
52. Mello P, Franger M, Boujaoude Z, Adaimy M, Gelfand E, Kass J et al. Night and day proteinuria in patients with sleep apnea. Am J Kidney Dis 2004;44:636-41.
53. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010;121:1014-21.
54. Osman EZ, Osborne J, Hill PD, Lee BWV. The Epworth Sleepiness Scale: can it be used for sleep apnoea screening among snorers? Clin Otolaryngol 1999;24:239-41.
55. Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A et al. Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010;2:46ps42.